Literature DB >> 17187026

Retinal pigment epithelial tear following intravitreal bevacizumab.

S J Bakri, S P Patel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17187026     DOI： 10.1038/sj.eye.6702700

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  4 in total

1.  Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis).

Authors:  David Sarraf; Anthony Joseph; Ehsan Rahimy
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

2.  Serum pigment epithelium-derived factor: Relationships with cardiovascular events, renal dysfunction, and mortality in the Veterans Affairs Diabetes Trial (VADT) cohort.

Authors:  Kelly J Hunt; Alicia J Jenkins; Dongxu Fu; Danielle Stevens; Jian-Xing Ma; Richard L Klein; Madona Azar; Sarah X Zhang; Maria F Lopes-Virella; Timothy J Lyons
Journal:  J Diabetes Complications       Date:  2019-07-26       Impact factor: 2.852

Review 3.  Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?

Authors:  Focke Ziemssen; Salvatore Grisanti; Karl Ulrich Bartz-Schmidt; Martin S Spitzer
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

4.  Physical disruption of cell-cell contact induces VEGF expression in RPE cells.

Authors:  Farhad Farjood; Elizabeth Vargis
Journal:  Mol Vis       Date:  2017-07-17       Impact factor: 2.367
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.